Back to
Amundi
KNSA
5 quarters
Position history for
Amundi's holdings in Kiniksa Pharmaceuticals International, plc
No. Amundi exited its KNSA (Kiniksa Pharmaceuticals International) position in Q1 2026. Its Q4 2025 13F listed 23,496 shares worth $969,210. Amundi first reported KNSA in Q1 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$347,551
Total Shares Change
-15,972
Quarter-by-Quarter History